Chi Advisors LLC Bluebird Bio, Inc. Transaction History

Chi Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$16.59 - $33.89 $132,720 - $271,120	-8,000 Closed	0 $0
Q2 2020 Aug 12, 2020	BUY	$27.12 - $45.97 $54,240 - $91,940	2,000 Added 33.33%	8,000 $488,000
Q1 2020 May 14, 2020	SELL	$26.16 - $63.5 $52,320 - $127,000	-2,000 Reduced 25.0%	6,000 $276,000
Q4 2019 Feb 14, 2020	SELL	$46.96 - $61.67 $187,840 - $246,680	-4,000 Reduced 33.33%	8,000 $702,000
Q3 2019 Nov 12, 2019	BUY	$59.47 - $93.1 $713,640 - $1.12 Million	12,000 New	12,000 $1.1 Million

128

62.8M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $598M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Chi Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Chi Advisors LLC with notifications on news.